Stocktoria
Aura Biosciences, Inc. AURA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-29
Aura Biosciences, Inc. statistics & valuation
Market cap$724.1M
P / B5.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -62.7% | -47.6% | -30.0% | -26.2% | -22.0% |
| Return on equity | -77.6% | -57.2% | -33.8% | -30.0% | -23.1% |
| Current ratio | 8.15 | 10.77 | 18.76 | 18.81 | 20.90 |
Source: SEC EDGAR filings · CIK 0001501796 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.